Adrenoceptor-linked 4scalcium uptake was investigated in platelets from diabetic rats (hyperglycaemic, streptozotocin-induced, of 60 days duration). Basal uptake was markedly enhanced in platelets from diabetic rats compared with controls. However, whereas adrenaline-stimulated uptake was unchanged, isoprenaline-stimulated uptake was significantly reduced and noradrenaline-stimulated uptake significantly increased. These latter data indicate that there are differential alterations of adrenoceptor subtypes in diabetes (i.e. an increase in alpha-but decrease in beta-adrenoceptors). These changes in calcium uptake and in adrenoceptor activity may relate to altered platelet function known to occur in experimental diabetes. Furthermore, the similarity of the rat platelet with that of the human (in terms of absolute calcium uptake, responses to agonists and changes in diabetes), renders the rat platelet an appropriate model for studying calcium dynamics and linked adrenoceptors in diabetes.
Platelets from patients with diabetes mellitus (DM) are reported to be hyperaggregable, particularly when microand macro-vascular complications are present (Hendra &. Betteridge 1989) . Since platelet activity is dependent on calcium (Rink &. Sage 1990), we recently investigated 4scalcium uptake by washed platelets from patients with DM and found marked different'ial alterations of calcium fluxes rGill et 01. 1992a). Similar findings were obtained by Bergh et al. (1989) . We have also shown that in man, adrenoceptor activation elicits calcium uptake in human platelets (Gill et al. 19911 and thatthis is altered in conditions associated with hyperaggregability of platelets (Gill et al. 1992bJ . In a subsequent study, we found that [ 4S Ca 2 +] uptake linked to adrenoceptor-Correspondence to: D P Mikhailidis Accepted 30 March 1993 activation in human platelets reflects changes of calcium associated with signal transduction mechanisms (i.e. activation of protein kinases), rather than reflecting an influx of calcium from extracellular fluid to the cytosol (Gill et al. 1993) .
Animal models provide basic information and allow for preliminary investigation of novel drugs aimed at treating diabetes. It is therefore important to establish that the properties of any given cell type are similar to those in humans. In the context of the present study, platelets from rats with DM are hyperaggregable when compared to controls (Eldor et ai. 1978) . Furthermore, alpha-adrenoceptor and beta-adrenoceptor activation respectively, potentiate and inhibit rat platelet aggregation (Yu &. Latour 1978) . In order to explore whether the platelet of the rat is an appropriate model for studying calcium fluxes, the effect of Laboratory Animals (1994) 28. 143-147 adrenoceptor agonists [isoprenaline [mainly betaL adrenaline [alpha and beta] and noradrenaline [mainly alpha, but also betad ) on 45calcium uptake was investigated in platelets obtained from rats with streptozotocin-induced OM.
Materials and methods

Materials
Adrenaline bitartrate, noradrenaline bitartrate, isoprenaline HCI, prostaglandin EI [PGE I ) and streptozotocin were obtained from Sigma Chemical Co (Poole, Dorset, UK). 45Calcium chloride was purchased from Amersham Radiochemicals (Amersham, UK) . Buffer constituents were all purchased from BDH-Merck Ltd (Poole, Dorset, UK).
Induction of diabetes
All experiments were carried out using male Sprague Dawley rats with an initial body weight of 250 g. Non-ketonuric, hyperglycaemic diabetes was induced by injecting streptozotocin (STZ) intravenously 165mgkg-1 body wt). These rats developed glycosuria but not ketonuria or haematuria. The diabetic rats were fed ad libitum with Diet 41B (Grain Harvester, Kent, UK) and allowed free access to water. The study also included 7 agematched controls.
Urine was monitored 2 days after the injection of STZ for the presence of glucose (Multistixj Ames Division, Miles Laboratories Ltd, Stoke Poges, Bucks, UK) which confirm the development of diabetes. After 8 weeks, rats were anaesthetized with pentobarbitone (90mg kg-1 intraperitoneally; Sagatal: May and Baker Ltd, Dagenham, UK) and blood was collected by cardiac puncture for preparation of platelets. Plasma glucose concentration was determined using a glucose oxidase method on a YSI glucose analyser (Model 23ami Beckman Ltd, High Wycombe, Bucks, UK).
When samples were collected for platelet studies there was a significant difference (P<0.001) in body weights between control Wasan, Grossie & Lopez-Berestein (n = 7) and diabetic rats (n = 7): Controls, 481.5 ± 10.4 gj 2 month diabetic, 248.7 ± 8.5 g. Plasma glucose concentration was also significantly different (P<O.OOl) between both groups: Controls, 8.5 ± 0.42 mmol/lj 2 month diabetic, 29.9 ± 0.75 mmolll.
Preparation of washed platelets and 45calciuLn uptake
Blood was placed in 3.8% trisodium citrate (1 vol to 9 vol of blood) and platelet-rich plasma (PRP) prepared by centrifugation at x 160 g for 15 min and pH adjusted to 6.1 with 1M citric acid. platelet pellets were then prepared by centrifugation of PRP at 550g for 10 min and washed with HEPES buffer A (composition: 140 mmol/l sodium chloride, 2.7 mmolll potassium chloride, 1 mmolll ethylenediaminetetracetic acid, 0.001 prostaglandin Ell 3.8 mmoUI N-2-hydroxyethy lpiperazine-N' -2-ethanesulfonic acid (HEPES), 0.1 % glucose and 0.1 % bovine serum albumin; adjusted to pH 7.6 with Tris base). The washed platelets were resuspended in calcium-free HEPES buffer B lcomposition: 140 mmol/l sodium chloride, 2.7 mmolll potassium chloride, 3.8 mmolll N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES), 8.0 mmol/l di-sodium hydrogen orthophosphate, 1.5 mmoUI potassium dihydrogen orthophosphate, 0.1 mmol/l magnesium chloride, 1mmoUI glucose; adjusted to pH 7.6 with Tris base). In both control and diabetic rats platelet count was adjusted so that the final count from each animal was 2 x 1011 /l for experiments on 45calcium uptake. 45Calcium uptake by platelets was carried out as previously described (Gill et al. 1991 (Gill et al. , 1992a . Aliquots of washed resuspended platelets were incubated in triplicate with 28 kBq 45calcium chloride and varying concentrations of agonists ( Gill et al. 1991) . The reaction was terminated by the addition of 2 ml of ice cold HEPES buffer B containing 7 mmol/l ethylene glycol-bis-(B-aminoethyl etherl N,N,N' N'tetraacetic acid followed by rapid centrifugation at 10 000 g for 30 sec in an Eppendorf microfuge. The platelet pellets formed were washed twice with HEPES buffer B and the pellets left overnight in 0.5% Triton. Liquid scintillation fluid (10 ml, Liquiscint; National Diagnostics, Hull, England) was added to each sample and measured for radioactivity on a beta particle counter (Rackbets 1210j LKB Wallac, Turku, Finland). Results with agonists are expressed as pmoles of 45calcium taken up by 10 9 platelets in 1 min, calculated by subtracting basal 45calcium from stimulated values. Statistical analysis was by the Wilcoxon test (2-tailed).
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Results
In platelets from control rats, adrenaline, isoprenaline and noradrenaline all stimulated 45calcium uptake [Fig 11. Basal (unstimulated) 45calcium uptake was significantly increased in platelets from diabetic rats when compared with controls (Fig 1) . Following subtraction of basal from stimulated values, noradrenaline-stimulated 45calcium uptake was significantly increased whereas isoprenaline-stimulated 45calcium uptake was significantly diminished in platelets from rats with DM when compared with controls [ Table 1 ). Adrenaline-stimulated uptake was unchanged (Table 1) . These latter data indicate that beta-adrenoceptor activity is diminished whereas alpha-adrenoceptor activity is increased in diabetic rat platelets.
Discussion
These data firstly demonstrate that platelets from rats possess similar adrenoceptor-mediated calcium uptake mechanisms to those found in man (Gill et al. 1991 (Gill et al. , 1992a , i.e. both alpha-and beta-adrenoceptor agonists stimulate the uptake of 45calcium (Gill et al. 1991) . It should be noted that although alpha-and beta-adrenoceptor activation is associated with stimulation and inhibition of platelets, respectively (Yu & Latour 1978, Kerry & Scrutton 19831, we found 45calcium uptake in response to these agonists reflects changes associated with signal transduction rather than changes of intracellular cytosolic calcium (Gill et al. 1991 (Gill et al. , 1993 . Thus, the activation of both stimulatory and inhibitory receptors results in an alteration of calcium uptake [probably at the plasma membrane level) which appears to be involved with: ral activation of protein kinase C (in the case of stimulators) and, [b) protein kinase A activation in the case of inhibitors (Gill et al. 1993) . FurthermoreJ the amounts of catecholamines that elicit the uptake of 45calcium more closely approximate physiological concentrations, i.e. picomolar range (Smith et al. 1989; Chamberlain et al. 1990 ) than the micromolar range that modulates platelet aggregation (Yu & Latour 1978J Kerry & Scrutton 1983 . The marked increase in basal calcium uptake in platelets from diabetic rats is similar to that found in human insulin-dependent diabetics (Gill et al. 1992a) . The actual amount of 45calcium taken up by the rat platelet is also similar to that of the human (Gill et ai. 1991J 1992a (Gill et ai. 1991J ,b, 1993 . Thus, the rat platelet can be used as a model for human platelets J at least for studies on calcium uptake and linked adrenoceptorsJ when studying platelet changes in diabetes. A more complete study on radioligand binding and studies with various adrenoceptor agonists and antagonists on calcium uptake by rat platelets is currently under way at our laboratory . Following subtraction of basal from stimulated values J it became apparent that there was a respective increase and decrease in alpha-and beta-adrenoceptor activity in platelets from diabetic rats. Since adrenaline is intrinsically both an alpha-and betaadrenoceptor agonist, the opposing agonist effects lead to no observable changes in adrenaline-stimulated 45calcium uptake in platelets from diabetic animals. Although we are aware of no systematic studies on adrenoceptor changes (using either functional tests or ligand binding) in platelets from diabetic rats or diabetic patients, marked disturbances of adrenergic systems in other tissues have been reported in OM. For example J there are increases in alphaadrenoceptor but diminished beta-adrenoceptor activity in cardiac, smooth muscle and neural tissue (Tomlinson et al. 1992 ). Furthermore J Betteridge et al. (1982) have demonstrated that PGIrstimulated adenylate cyclase is significantly diminished in platelets from diabetic patients. Since beta-adrenoceptors are thought to act via activation of adenylate cyclase (Jakobs et ai. 1978) in platelets, the present reduction in beta-adrenoceptor-linked calcium uptake are consistent with a defect in adenylate cyclase [and associated signal transduction mechanisms) in platelets in OM. Since it has been proposed that blood borne cells (such as platelets, leucocytes and erythrocytes)may reflect generalalterations of adrenoceptor activity in other tissues (Jeremy et ai. 1991) , the present approach may be of use in studying general adrenoceptor changes in experimental and human OM.
As mentioned earlier, it has been proposed that the present methodology reflects changes of calcium dynamics at the plasma membrane via association of calcium with protein kinases [Gill et al. 1992a,b,c) . In turn, alteration of plasma membrane lipid content alters other plasmalemma functions including fluidity, ionic fluxes and binding as well as receptor (including adrenoceptor) activity (Jeremy 1992) . In this context, OM is associated with a marked alteration of lipid profiles (fatty acids, phospholipids) in the plasma membranes of platelets (Kalofoutis & Lekakis 1981 , Prisco et al. 1983 . In experimental fasting and in anorexic humans (associated with altered lipid profiles)J a generalized increase and decrease in alpha-and beta-adrenoceptors J respectively, has also been reported (Gill et ai. 1992b J Jeremy et ai. 1992 , and the possibility that lipids determine the present changes warrants further investigation.
